Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

India Globalization Capital Inc (IGC)

India Globalization Capital Inc (IGC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 34,822
  • Shares Outstanding, K 39,571
  • Annual Sales, $ 5,120 K
  • Annual Income, $ -4,100 K
  • 60-Month Beta 4.38
  • Price/Sales 6.88
  • Price/Cash Flow N/A
  • Price/Book 1.10
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.85 +2.94%
on 11/12/19
1.09 -19.61%
on 10/17/19
-0.01 (-1.20%)
since 10/11/19
3-Month
0.85 +2.94%
on 11/12/19
1.31 -33.21%
on 09/19/19
-0.21 (-18.98%)
since 08/12/19
52-Week
0.25 +250.00%
on 12/31/18
3.30 -73.48%
on 02/25/19
-0.24 (-21.17%)
since 11/12/18

Most Recent Stories

More News
IGC Reports Financial Results for the Quarter Ended September 30, 2019

India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended September 30, 2019, which is the second quarter of its 2020 fiscal year.

IGC : 0.85 (-3.41%)
IGC Opens Marketing and Research Hub in Colombia

India Globalization Capital, Inc. (NYSE: IGC) announced today that it has opened a marketing and research office in Colombia, South America. Hamsa Biochem SAS, a new beneficially owned subsidiary of IGC,...

IGC : 0.85 (-3.41%)
IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study

India Globalization Capital, Inc. (NYSE: IGC) announced today that the Institutional Review Board ("IRB"), in Puerto Rico, approved its protocol for a double-blind, placebo-controlled, efficacy, safety...

IGC : 0.85 (-3.41%)
IGC Reports Financial Results for the Quarter Ended June 30, 2019

India Globalization Capital, Inc. (NYSE American: IGC) today announced its financial results for the quarter ended June 30, 2019, which is the first quarter of its 2020 fiscal year.

IGC : 0.85 (-3.41%)
Lifshitz & Miller LLP Announces Investigation of Amneal Pharmaceuticals, Inc., CareDx, Inc., Casa Systems, Inc., India Globalization Capital, Inc., Just Energy Group Inc., LegacyTexas Financial Group, Inc., Maxar Technologies Inc., and Unum Group

Amneal Pharmaceuticals, Inc. (AMRX)

CDNA : 20.28 (-3.38%)
IGC : 0.85 (-3.41%)
JE : 2.32 (-2.93%)
LTXB : 42.54 (-3.56%)
CASA : 3.43 (-2.56%)
UNM : 30.16 (+1.07%)
Savvy Investors Seek out Innovative Cannabis Opportunities

The booming cannabis industry has created opportunities for many driven entrepreneurs. In particular, many may be looking to launch something standard such as operating a retail dispensary or starting...

STZ : 183.83 (-0.37%)
BKLLF : 0.0167 (-7.73%)
CODE.CN : 0.025 (unch)
IGC : 0.85 (-3.41%)
CBWTF : 0.5700 (+3.24%)
XLY.VN : 0.760 (+2.70%)
CNAB : 0.3200 (-0.65%)
IVITF : 0.1225 (+1.49%)
GENE.VN : 0.150 (-6.25%)
Studies Add Validity to Cannabis' Medical Capabilities

All over the world, the debate over cannabis' ability to replace traditional medicines goes on as more medicinal applications continue to emerge. A handful of countries have already adopted medical cannabis...

BKKSF : 0.1900 (-5.61%)
TTT.VN : 0.310 (+6.90%)
IGC : 0.85 (-3.41%)
CBWTF : 0.5700 (+3.24%)
XLY.VN : 0.760 (+2.70%)
IMLFF : 0.2100 (-6.87%)
IN.TO : 0.28 (-3.45%)
IVITF : 0.1225 (+1.49%)
GENE.VN : 0.150 (-6.25%)
Consumer Access to CBD Products Grows as National Retailers Stock Shelves

After the U.S. Farm Bill passed, CBD-based products have sprung up across the entire country. U.S. President Donald Trump signed the bill into effect in late 2018 after witnessing immense support pouring...

NLBS : 0.1100 (-8.33%)
IGC : 0.85 (-3.41%)
SPRWF : 0.6529 (+0.45%)
FIRE.TO : 0.87 (+1.16%)
TRTC : 0.2635 (-1.35%)
IVITF : 0.1225 (+1.49%)
GENE.VN : 0.150 (-6.25%)
IGC Announces Continued Educational Initiatives in Support of Hyalolex

India Globalization Capital, Inc. (NYSE: IGC) announces that it will host educational conferences in two of the largest cities in Puerto Rico on April 27, 2019 (San Juan) and April 28, 2019...

IGC : 0.85 (-3.41%)
Data Projects Consumers are Flocking to CBD Products for Medical and Recreational Uses

In light of the rapid expansion of the cannabis market, many wonder what will be the next step for the industry. As of now, the cannabis market is heavily hindered by the lack of clinical trials and research,...

CLSH : 0.2296 (+0.92%)
CLSH-U.CN : 0.300 (+7.14%)
TCNNF : 10.5700 (-4.34%)
TRUL.CN : 13.970 (-4.12%)
HEXO : 2.12 (unch)
HEXO.TO : 2.81 (unch)
CURLF : 4.9300 (-0.40%)
CURA.CN : 6.530 (-0.31%)
IGC : 0.85 (-3.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade IGC with:

Business Summary

India Globalization Capital, Inc. is engaged in developing phytocannabinoid-based therapies. The company's patent filing for the indications of pain, medical refractory epilepsy and cachexia using phytocannabinoids. It also engage in leasing, trading, developing and managing infrastructure and real estate...

See More

Key Turning Points

2nd Resistance Point 0.91
1st Resistance Point 0.90
Last Price 0.85
1st Support Level 0.87
2nd Support Level 0.85

See More

52-Week High 3.30
Fibonacci 61.8% 2.13
Fibonacci 50% 1.77
Fibonacci 38.2% 1.42
Last Price 0.85
52-Week Low 0.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar